These groups received intravenous treatments of oridonin, orid-liposome, orid-liposome-MAL, and TLR2 pep-orid-liposome at a dosage of 5 mg/kg (equivalent to the active ingredient of oridonin), with PBS serving as the control, administered every other day
In addition to the remaining ACE2 expression, another possible explanation for this heterogeneity in COVID-19 susceptibility could be that that independently of ACE2, the quality of life for people with cystic fibrosis may depend on contributions from non-CFTR modifier or bystander genes 69,70,71,72,73,74,75
If youve been treating suspected Candida without lasting improvementor youre wondering whether Candida is actually contributing to your symptomstesting provides clarity
doi: 10.1053/j.ajkd.2014.01.431